ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Xinjiang Wang
Matched on ORCID iD 0000-0002-1347-4112; OpenAlex author ID A5059138390. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53. Last author DOI 10.1158/1535-7163.mct-21-0728↗
- Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.10.029↗
- An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. Co-author DOI 10.1186/s13046-018-0899-8↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dhyan Chandra · 2 shared papers, 2018–2022 · strength 0.24
- Paper Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heav… DOI 10.1158/1535-7163.mct-21-0728↗
- Paper Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. DOI 10.1016/j.canlet.2017.10.029↗
- Junhui Li · 1 shared paper, 2022 · strength 0.16
- Xiang Ling · 1 shared paper, 2018 · strength 0.08
- Fengzhi Li · 1 shared paper, 2018 · strength 0.08
- Sandeep Kumar · 1 shared paper, 2018 · strength 0.07
- Steven N. Hochwald · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.